Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rossanna C Pezo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Oncology (Toronto, Ont.)|July 25, 2025
Role of Circulating Tumor DNA in Adapting Immunotherapy Approaches in Breast CancerSudhir Kumar, Rossanna C Pezo
Breast Cancer (Tokyo, Japan)|January 11, 2021
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic reviewMelika Shirdarreh, Rossanna C Pezo
Journal of Cellular Biochemistry|May 5, 2007
Nuclear microenvironment in cancer diagnosis and treatmentRossanna C Pezo, Robert H Singer
Clinical Breast Cancer|April 26, 2026
Patterns of Disease Progression in Advanced Breast Cancer Patients Treated With Cyclin D Kinase 4/6 Inhibitors: Prognostic and Therapeutic ImplicationsSudhir Kumar, Neha Pathak, Rossanna C Pezo
Therapeutic Advances in Gastroenterology|September 27, 2019
Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicitiesRossanna C Pezo, Matthew Wong, Alberto Martin
JAAD International|August 19, 2021
Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte-associated protein 4 therapy: A retrospective cohort studySheida Naderi-Azad, Faisal Sickandar, Rossanna C Pezo
Journal of Skin Cancer|August 2, 2021
Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with ImmunotherapyManish D Angrish, Arun Agha, Rossanna C Pezo
Cancer Medicine|May 27, 2020
Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic reviewAdam S Komorowski, Helen J MacKay, Rossanna C Pezo
Heart (British Cardiac Society)|May 27, 2019
Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugsRossanna C Pezo, Andrew T Yan, Craig Earle, et al.
Science (New York, N.Y.)|August 6, 2002
Single-cell gene expression profilingJeffrey M Levsky, Shailesh M Shenoy, Rossanna C Pezo, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|July 25, 2025
Role of Circulating Tumor DNA in Adapting Immunotherapy Approaches in Breast CancerSudhir Kumar, Rossanna C Pezo
Breast Cancer (Tokyo, Japan)|January 11, 2021
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic reviewMelika Shirdarreh, Rossanna C Pezo
Journal of Cellular Biochemistry|May 5, 2007
Nuclear microenvironment in cancer diagnosis and treatmentRossanna C Pezo, Robert H Singer
Clinical Breast Cancer|April 26, 2026
Patterns of Disease Progression in Advanced Breast Cancer Patients Treated With Cyclin D Kinase 4/6 Inhibitors: Prognostic and Therapeutic ImplicationsSudhir Kumar, Neha Pathak, Rossanna C Pezo
Therapeutic Advances in Gastroenterology|September 27, 2019
Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicitiesRossanna C Pezo, Matthew Wong, Alberto Martin
JAAD International|August 19, 2021
Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte-associated protein 4 therapy: A retrospective cohort studySheida Naderi-Azad, Faisal Sickandar, Rossanna C Pezo
Journal of Skin Cancer|August 2, 2021
Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with ImmunotherapyManish D Angrish, Arun Agha, Rossanna C Pezo
Cancer Medicine|May 27, 2020
Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic reviewAdam S Komorowski, Helen J MacKay, Rossanna C Pezo
Heart (British Cardiac Society)|May 27, 2019
Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugsRossanna C Pezo, Andrew T Yan, Craig Earle, et al.
Science (New York, N.Y.)|August 6, 2002
Single-cell gene expression profilingJeffrey M Levsky, Shailesh M Shenoy, Rossanna C Pezo, et al.
Pageof 4